Lead (Pb) is a toxic heavy metal affecting human health; it is known to be harmful to various organs or systems, yet the mechanisms by which Pb influences immune cell development remain to be defined. In this study, we show that Pb exposure (1250 ppm via drinking water) selectively impacted the development of myeloid cells (myelopoiesis). After Pb treatment of adult C57BL/6 mice, the numbers of granulocyte-macrophage progenitors (GMP) were consistently reduced, whereas the numbers of myeloid cells were increased at week (wk) 1 and decreased at wk8 after initiating the Pb exposure. Functional assays indicate that Pb accelerated GMP differentiation in a reactive oxygen species-dependent manner after treatment for 1 week and inhibited common myeloid progenitor differentiation by upregulating interferon regulatory factor 8 (IRF8) expression after treatment for 8 weeks. Consistent with the distinct Pb influences on myeloid cells observed at wk1 and wk8, Pb caused an inflammatory environment in vivo at wk8, but not at wk1. Furthermore, like the observations in mice during the Pb exposure, bloods from humans occupationally exposed to Pb had their numbers of monocytes, neutrophils and GMP negatively associated with the Pb concentration, whereas IRF8 expression in common myeloid progenitor, but not GMP, was positively correlated with the Pb concentration. These data suggest an occupationally relevant level of Pb exposure preferentially influences myelopoiesis involving reactive oxygen species and IRF8, which may contribute to the current understanding of the hematopoietic toxicology of Pb.
Lead (Pb) is a heavy metal that is detectable in the living environment including old houses, paintings, toys, atmosphere, foods, and even drinking water (Dixon et al., 2009; Driscoll et al., 2016; Yoshinaga, 2012) . Even at very low exposure levels, Pb is toxic to numerous organ systems, such as the immune, nervous, and renal systems (Dietert and Piepenbrink, 2006; Evens et al., 2015; Flora et al., 2012) . At present, it is believed that Pb is not required for any normal physiological process in humans, and thus any level of Pb exposure is considered detrimental (Vorvolakos et al., 2016) . Pb is detectable in blood and is associated with human health effects at certain blood concentrations, making Pb poisoning a significant global public health problem (Arbuckle et al., 2016; Bello et al., 2016; Buser et al., 2016; Dixon et al., 2009; Zhang et al., 2016a) .
Hematopoiesis is the process of generating all blood cells from the hematopoietic stem cells (HSC). HSC differentiate into multipotent progenitors (MPP), and MPP further differentiate into committed myeloid, lymphoid, and erythroid progenitors, which eventually give rise to myeloid cells, lymphocytes, and erythrocytes/platelets, respectively (Wang and Wagers, 2011) . Hematopoiesis is tightly regulated in vivo and the process can be affected by various environmental stresses through direct or indirect interactions with hematopoietic stem and progenitor cells (HSPC) (Baldridge et al., 2011) . For instance, lipopolysaccharide (LPS) directly activates HSC while ehrlichia infection promotes monopoiesis in an IFNc-dependent manner in mice (Nagai et al., 2006; Zhang et al., 2013) . Previously, we reported that environmentally relevant cadmium-exposure drove myelopoiesis while suppressing lymphopoiesis in mice (Zhang et al., 2016b) , which indicates that an environmental xenobiotic can influence differentially HSPC and hematopoiesis. Once Pb has entered the body, it is distributed to almost all soft tissues including the bone marrow (BM), where most HSPC reside (Nombela-Arrieta et al., 2013) . Pb impacts the expression of various cytokines, and some of these cytokines affect HSPC (Dobrakowski et al., 2016; Kasten-Jolly et al., 2010; Li et al., 2013; Zhang et al., 2013) . Indeed, Pb has been reported to impact hematopoiesis. For instance, Pb is known to affect erythropoiesis causing aplastic anemia with reduced corpuscular hemoglobin and hematocrit alterations (Ahamed et al., 2011; Dai et al., 2017) . In addition, Pb has been reported to influence the numbers of immune cells. For instance, a short period of occupational Pb exposure increased leukocytes and lymphocytes in human periphery bloods (Dobrakowski et al., 2016) . Other studies have shown that Pb treatment impaired thymic T cell development and reduced the numbers of mouse T cells and B cells (Fang et al., 2012; Kishikawa et al., 1997) . In accordance with these observations, an early study reported Pb increased the number of colony-forming units (CFU) generated from the total BM cells of mice after a single intraperitoneal injection (Burchiel et al., 1987) . Two in vitro studies published later indicated that Pb depressed CFU-granulocyte-macrophage (GM) production from human umbilical cord blood and mouse BM (Van Den Heuvel et al., 1997 , 1999 . Taken together, these studies suggest that Pb influences hematopoiesis at the progenitor stage. However, although Pb is known to impact hematopoiesis, to date, the mechanisms and molecules involved in Pb influences on immune cell development have been rarely investigated.
Because Pb pollution broadly exists in the living environment, a comprehensive understanding of the impacts and mechanisms of Pb influences on immune cell development is essential for public health. Therefore, the aim of this study was to investigate the mechanisms by which Pb alters immune cell development. We found that an occupationally relevant level of Pb exposure preferentially influences myelopoiesis at 2 distinct stages dependent on induction of reactive oxygen species (ROS) and interferon regulatory factor 8 (IRF8), respectively. Moreover, this process likely also occurs in humans.
MATERIALS AND METHODS
Mice and Pb treatment. About 6-to 8-week (wk)-old wild type C57BL/6 (B6) mice were purchased from Shanghai SLAC Laboratory Animal Co Ltd, China. Both sexes were equally used. All mice were housed in a SPF animal facility at Fudan University, with controlled temperature, humidity, and an artificial 12 h light on/12 h light off; 4-5 mice were housed per cage. The control Pb exposure was 0.01 lg/g in mouse food; normal drinking water contained no detectable Pb. Based on the doses of Pb in drinking water used in published animal studies (Chang et al., 2014; Queiroz et al., 2011; Tokar et al., 2010; Yu et al., 2014) , we performed preliminary experiments for dose selection and found that treatment with 1250 ppm of Pb via drinking water resulted in a blood Pb burden (about 40 lg/dl) comparable to the reported blood Pb concentrations in humans who worked in Pbbattery manufacturers (Kasuba et al., 2010; Rapisarda et al., 2016) . Thus, 1250 ppm of Pb in the form of Pb acetate in drinking water was provided to mice ad libitum in this study; 0.006% of acetic acid was added into the Pb solution to assist dissolution. The same concentration of Na acetate in 0.006% acetic acid drinking water was used as control. Preliminary experiments indicated that Pb influences on HSPC involved 2 distinct stages spanning 8 weeks. Thus, adult mice were treated with Pb or control for up to 8 weeks in our experiments. For in vivo anti-ROS assay, vitamin C (2 g/l) and melatonin (100 mg/l) (all from Sigma) dissolved in drinking water containing Pb were used as antioxidants and provided to mice for 1 week. This work was approved by Fudan University Animal Care and Use Committee.
Human subject participation and peripheral blood mononuclear cells harvest. A Total of 349 human subjects (132 females and 217 males) from a Pb-battery manufacturing plant in an east area of China volunteered to participate in this project. Written informed consents were provided to and signed by all the volunteers. This project was approved by Fudan University School of Public Health Ethics Committee. Peripheral bloods were harvested with sterile EDTA anticoagulant tubes. Routine blood examinations and blood Pb measurements were performed for all volunteers. Peripheral blood mononuclear cells (PBMC) were isolated from 185 volunteers (78 females and 107 males) using commercial human PBMC isolation kits (Biolegend, San Diego, California). PBMC were stored in À86 C in the presence of 90% FBS and 10% dimethyl sulfoxide until use.
Pb measurements. Human peripheral bloods were harvested as have described. Mouse bloods were harvested intracardially and EDTA was used as anticoagulant. Mouse BM homogenates were prepared as previously described (Zhang et al., , 2016b . Total protein concentration was measured with a bicinchoninic acid kit (Pierce, Rockford, Illinois) according to the manufacturer's instruction. Pb in the bloods and BM was measured using atomic absorption spectrometry (M6 MK2) (ThermoFisher Scientific, Waltham, Massachusetts) as previously reported (Macedoni-Luksic et al., 2015) .
Blood examinations. Blood examinations were performed with a hematology analyzer (LH 750, Beckman Coulter, Inc, California) according to the manufacturer's instruction. purchased from Sigma. Foxp3 nuclear staining kit purchased from eBioscience was used for nuclear factor staining with protocols provided by the manufacturer. ROS measurement was performed by incubating cells with DCFH-DA at 37 C for 30 min as previously described (Jing et al., 2013) . Apoptotic analyses were performed by incubating cells with anti-Annexin V in the presence of Annexin V binding buffer at room temperature for 30 min. Stained cells were analyzed with a BD LSR Fortessa and data were evaluated using FlowJo 9.3.2.
CFU assay. Total BM cells (2 Â 10 4 ) were seeded into each 35-mm petri dish containing 1 ml of methocult medium (STEMCELL Technologies, BC, Canada). The dishes were incubated with 5% CO 2 and !95% humidity at 37 C for 7 days. Thereafter, CFU for granulocyte-erythroid-macrophage-megakaryocyte (GEMM), GM, granulocyte (G), macrophage (M), and erythroid (E) were quantified under a microscope with 10Â magnification .
, and common lymphoid progenitors (CLP) (Lin À c-Kit low Scal-1 low ) from the BM of Pb-treated mice and control mice were seeded into each well (1000 cells/well; 24-well plate) precoated with irradiated OP9 cells (30 Gy) in the presence of IL-3, IL-7, Filt3L, GM-CSF, and SCF as previously described (Lai et al., 2005; Zhang et al., 2016b) . OP9 mesenchymal stem cells (MSC) were used to aid hematopoiesis. MPP and CLP were cocultured up to 12 days and CMP and GMP were cocultured up to 9 days. Thereafter, mature cells were analyzed through flow cytometry. Pretreatment of the sorted GMP with N-acetylcysteine (NAC; Sigma) for 3 h at 37 C was used to quench ROS. Addition of short hairpin RNA (shRNA) specific to mouse IRF8 (shRNA1 and shRNA2; target different sequences of mRNA for IRF8) to the coculture system was used to inhibit IRF8 expression in the sorted CMP. The kit for shRNA transfection was purchased from Invitrogen (Carlsbad, California). shRNA sequences were subcoloned into pSUPER plasmid and protocol was according to the pSUPER RNAi system provided by the manufacturer. The sequences for control (nonspecific) shRNA (nsshRNA), shRNA1, and shRNA2 were 5 0 - Statistics. Data were in the form of mean 6 SD. A Student's t test was used to compare between Pb-treated mice and controls. p < .05 was considered as the significant difference level.
RESULTS

The Blood Pb Level of Mice Was Comparable to Occupationally Relevant Levels
In this study, body weight was not affected by Pb exposure ( Figure 1A ), and the blood Pb level was comparable to that of human subjects occupationally exposed to Pb ( Figure 1B ) (Ghiasvand et al., 2016; Kalahasthi and Barman, 2016) . In addition, Pb was detectable in the BM of the Pb-exposed mice ( Figure 1C ).
Pb Selectively Reduced the Numbers of GMP in the BM of Mice
To investigate the Pb influences on hematopoiesis, we first quantified the numbers of different types of HSPC in the BM after Pb treatment for up to 8 weeks. The gating strategy for BM HSPC is shown in Figure 2A ; it was done as previously reported (Hur et al., 2016; McCabe et al., 2015; Vukovic et al., 2016; Zhang et al., 2016b) . Because no sex differences were observed, data from males and females were pooled together for analyses. The total numbers of BM cells as well as percentages of HSPC subsets during Pb exposure are summarized (Table 1) . During Pb exposure, the numbers of BM cells increased at wk1 and wk3, but decreased at wk8. Pb reduced the percentage of MPP (Lin À c-
, and decreased the percentages of GMP (Lin À c-Kit
) at wk1, wk3, and wk5. Since absolute numbers are more biologically relevant to hematopoiesis, we next quantified the absolute numbers for HSPC subsets. After Pb treatment, the numbers of long-term (LT)-HSC (Lin
in the BM were not affected by Pb exposure, whereas the numbers of GMP were consistently reduced throughout the Pb-exposure period (Figs. 2B and C). HSPC can be mobilized into the periphery under certain conditions (McCabe et al., 2015; Yuzugullu et al., 2015) . We next measured the numbers of GMP in the peripheral blood and spleen to rule out the possibility that the reduced numbers of GMP in the BM were due to increased mobilization to the periphery by Pb. As shown in Figures 2D and E, the numbers of GMP in the blood and spleen were also decreased by Pb exposure. Moreover, apoptosis analyses indicated the lower numbers of GMP in the BM after Pb treatment were not due to increased apoptosis ( Figure 2F ). Collectively, these data suggest that Pb treatment selectively reduced the numbers of GMP and influenced myelopoiesis in mice.
Pb Increased the Numbers of Myeloid Cells at an Early Stage While Reducing the Numbers of Myeloid Cells at a Late Stage in Mice
Mature immune cells are differentiated from HSPC in mammals. Because Pb significantly reduced the numbers of GMP in the BM, we next quantified mature immune cells to test whether mature myeloid cells were also decreased during Pb treatment. The percentages of BM mature immune cells are summarized in Table 2 . Pb increased the percentages of monocytes (CD11b þ Ly6C hi ) in the BM at wk1 and wk3. As shown in Table 3 , Pb did not influence the total numbers of thymic cells or the percentages of T cell subsets at wk8. Although Pb did not affect the total numbers of splenic cells, Pb increased the percentage of monocytes at wk1 while reducing it at wk8; Pb increased the percentage of neutrophils (CD11b þ Ly6C low Ly6G þ ) at wk1 while decreasing it at wk5 and wk8 (Table 4) . Further analyses of absolute numbers for the cell subsets were performed. During Pb exposure, the numbers of monocytes, neutrophils, and macrophages (CD11b (Figs. 3A and B) . Consistent with the Pb effects on immune cells in the BM and thymus, the numbers of monocytes and neutrophils in the spleen were increased at wk1 and decreased at wk5 and/or wk8, whereas the numbers of B cells and T cells (CD3
in the spleen were not influenced by Pb ( Figure 3C ). In addition, routine blood tests indicated Pb treatment increased the number of neutrophils at wk1, and decreased the numbers of monocytes and neutrophils at wk8; Pb treatment did not influence the numbers of lymphocytes ( Figure 3D ). Furthermore, apoptotic analyses indicated that Pb treatment did not increase the numbers of preapoptotic ( Figure 1) . Therefore, Pb treatment selectively increased development of myeloid cells at an early stage of exposure but decreased their development after a longer Pb exposure.
Pb Accelerated GMP Differentiation at wk1 and Suppressed CMP Differentiation at wk8 in Mice Because reduced numbers of phenotypic GMP were observed during Pb exposure, we next used a methocult assay to evaluate whether functional myeloid progenitors were also reduced by Pb exposure. As expected, the numbers of CFU for G and M, but not GEMM, GM, or E, generated from the total BM cells of Pb-treated mice, were reduced relative to those of control mice ( Figure 4A ). Next, flow cytometry-sorted progenitors from BM of Pb-treated mice and control mice were seeded into irradiated OP9 cells to test their differentiation potential ex vivo. Monocyte and neutrophil differentiation of CMP from Pb-treated mouse BM at wk8, but not at wk1, was suppressed relative to that from control mice ( Figure  4B ). On the other hand, monocyte and neutrophil differentiation of GMP from Pb-treated mouse BM at wk1, but not at wk8, was accelerated relative to that from control mice ( Figure 4C ). In contrast, Pb treatment did not influence differentiation of BM MPP (Supplementary Figure 2A) or CLP (Supplementary Figure 2B) ex vivo. These observations indicate that Pb promoted or accelerated myelopoiesis at GMP level at wk1, whereas it suppressed myelopoiesis at the CMP level at wk8.
Pb Increased ROS Production to Promote GMP Differentiation at wk1 in Mice A certain level of ROS production is required for maintaining physiological function of cells. Pb is able to induce enhanced ROS production causing oxidative stress in multiple cells (Liu et al., 2017; Su et al., 2016; Xu et al., 2016) . To investigate whether Pb influences on myeloid differentiation were due to increased expression of ROS, we measured ROS in CMP and GMP from BM of Pb-treated mice and control mice by incubating these progenitors with DCFH-DA, a nonfluorescent dye that can penetrate into live cells and be oxidized by ROS to become fluorescent. As indicated by mean fluorescence intensity (MFI) derived from DCFH-DA, ROS expression was increased in GMP, but not in CMP, at wk1, but not at wk8, after Pb treatment ( Figure 5A ).
To test whether Pb-promoted GMP differentiation in mice at wk1 was due to increased ROS production, we sorted BM GMP and then quenched ROS by incubating GMP with NAC, a known antioxidant. Thereafter, the processed GMP was cocultured with irradiated OP9 cells and their differentiation potential was measured ( Figure 5B ). Relative to GMP from control mice, monocytes differentiated from GMP of Pb-treated mice were increased and BM Pb concentration (C) were measured. Data were from 2 independent experiments. About 6 and 8 mice were used for the control and Pb group for each time point, respectively.
( Figure 5C ). However, after pretreatment with NAC, monocyte generation from GMP of control mice and Pb-treated mice was lowered and no differences among the groups were observed ( Figure 5C ). Neutrophil differentiation from GMP of control mice was delayed and less relative to that of Pb-treated mice ( Figure  5C ). Pretreatment with NAC diminished Pb-accelerated differentiation of GMP into neutrophils ( Figure 5C ). Next, we expected that the reduced number of GMP at wk1 during Pb treatment might be due to their accelerated differentiation. To test this, mice were treated with Pb in the presence or absence of antioxidant vitamin C or melatonin for 1 week, and thereafter GMP in the BM were quantified. As expected, antioxidant treatments restored the number of GMP in the BM during Pb treatment ( Figure 5D ). Pb Increased IRF8 Expression to Suppress CMP Differentiation at wk8 in Mice Because CMP differentiation was suppressed by Pb exposure at wk8, we next sought to investigate which nuclear transcription factor was dominant in this process. We screened numerous transcription factors in BM CMP during Pb exposure and found that IRF8, a transcription factor known to modulate myelopoiesis (Tamura et al., 2015; Yanez and Goodridge, 2016) , was increased in CMP at wk8, but not wk1, during Pb-treatment; IRF8 expression was not altered in GMP during Pb exposure (Figs. 6A and B). We next investigated whether the suppression of CMP differentiation at wk8 during Pb-treatment was affected by increased IRF8 expression. To test this, FACS-sorted CMP from Pbtreated mice and control mice at wk8 were cocultured with irradiated OP9 cells in the presence of shRNAs specific to IRF8 or nonspecific control shRNA as indicated in Figures 6C and D. As shown in Figure 6E , relative to control shRNA, shRNAs specific to IRF8 promoted CMP differentiation into myeloid cells both with CMP from Pb-treated mice and control mice. These data suggest that Pb increased IRF8 activation to suppress CMP differentiation at wk8 in mice.
Pb Did Not Cause Damage to Bone Structure but Induced Systematic Inflammatory Environment in Mice at wk8
The microenvironment in the BM significantly influences HSPC, and bone is crucial for maintaining this microenvironment (Reagan and Rosen, 2016) . Because different Pb effects on myeloid progenitors were observed in mice at wk1 and wk8, we sought to investigate whether this phenomenon was associated with bone damage from the Pb exposure. After HE staining, no significant histological alterations of bone were observed at wk1 and wk8 after Pb exposure ( Figure 7A ). Pb has been reported to induce a systematic inflammatory environment and alterations of growth factors that can influence hematopoiesis (Boskabady et al., 2016; Kasten-Jolly et al., 2010) . Thus, we next investigated whether Pb caused different inflammatory environments at wk1 and wk8. After Pb treatment for 8 weeks, but not for 1 week, serum IL-4, IL-5, IL-10, eotaxin, GM-CSF, MCP-1, MIP-1a, MIP-1b, RANTES, and TNFa were increased, whereas serum IFNc was reduced ( Figure 7B ). Pb treatment did not influence serum IL-1a, IL-1b, IL-2, IL-3, IL-6, IL-9, IL-12p40, IL-12p70, IL-13, IL-17A, G-CSF, KC, or MIG expressions (data not shown and Figure 7B ). On the other hand, Pb treatment for 8 weeks, but not for 1 week, increased BM IL-4, IL12p70, IL-10, eotaxin, GM-CSF, IFNc, MCP-1, MIP-1a, MIP-1b, RANTES, TNFa, and MIG expressions ( Figure 7C ). Pb treatment did not influence BM IL-1a, IL-1b, IL-2, IL-3, IL-5, IL-6, IL-9, IL12p40, IL-13, IL-17A, G-CSF, or KC expressions (data not shown). Collectively, these data suggest that a Pb-induced systematic inflammatory environment likely led to differential Pb modifications on myeloid progenitors in mice at the late stage of Pb exposure.
Pb Levels Were Negatively Associated With Myeloid Cells and Positively Associated With IRF8 Expression in CMP in the Peripheral Bloods of Human Subjects
Because Pb has been detectable in human blood (Dixon et al., 2009) , we investigated whether Pb modulations of myelopoiesis observed in mice also occurred in humans that were occupationally exposed to Pb. Human bloods were harvested for Pb measurements and routine blood tests, and PBMC were prepared for cellular and transcription factor analyses. As expected, Pb levels were negatively correlated with the numbers of neutrophils, but not the numbers of lymphocytes, in the blood; Pb levels also tended to be negatively associated with the numbers of monocytes in the peripheral bloods of humans ( Figure 8A ). Next, we sought to determine whether blood Pb concentrations were associated with human myeloid progenitors. The gating strategy for human myeloid progenitors in the peripheral bloods was used as previously reported (Wu et al., 2014) . We quantified GMP (Lin
and IRF8 expression in myeloid progenitors in peripheral bloods of human subjects. Similar to mice, humans with higher blood Pb concentrations also had fewer GMP ( Figure 8B ). In addition, IRF8 expressions in CMP (Lin mice were used for Pb group at wk1 and wk8, respectively. Asterisk indicates a significant difference relative to the counterpart control. n.s. indicates no significant differences.
concentrations ( Figure 8C ). These data indicate that Pb appears to promote IRF8 expression and suppress human myelopoiesis of CMP.
DISCUSSION
Pb has been reported to modulate immune cell development in a variety of studies, yet the molecules and mechanisms involved have not been fully identified. Although numerous studies have suggested that Pb influences on hematopoiesis are complex (Burchiel et al., 1987; Fang et al., 2012; Kishikawa et al., 1997) , in this study, we report that an occupationally relevant level of Pb exposure preferentially impacts myelopoiesis. Two distinct stages of myelopoiesis existed during Pb exposure, namely promotion of myelopoiesis at the early stage (wk1) and suppression of myelopoiesis at the late stage (wk8).
Relative to percentages of HSPC and mature immune cells, the absolute numbers of these cells are more relevant to hematopoiesis. The promotion of myelopoiesis at wk1 during Pb exposure was mediated by increased ROS expression in BM GMP. Pb has been reported to induce oxidative stress in various types of cells both in vivo and in vitro (Liu et al., 2017; Staff, 2015; Su et al., 2016) . One possible mechanism is that Pb has high affinity for intracellular glutathione causing interference with ROS clearance (Jaishankar et al., 2014) . This process likely accelerated the GMP differentiation at the early stage of Pb exposure, resulting in generation of more monocytes and neutrophils. The number and the differentiation of CMP were not changed by Pb exposure at wk1, indicating the replenishment of GMP by CMP differentiation retained at the same level relative to that of controls. Therefore, it is inferred that at the early stage of exposure, Pb-induced ROS accelerated GMP differentiation, resulting in reduced numbers of GMP. This is also supported by the observation that Pb did not increase GMP apoptosis or mobilization to the periphery, and in vivo treatment with antioxidant vitamin C or melatonin restored the number of GMP in the BM of mice treated with Pb.
At the late stage of Pb exposure, the differentiation of CMP, but not that of GMP, was suppressed by Pb. Because mature myeloid cells are suggested to be directly differentiated from GMP, the reduction of mature myeloid cells at wk8 during Pb exposure was likely due to reduced numbers of GMP. The decreased numbers of GMP likely were caused by the suppression of CMP differentiation. Moreover, we found that the suppression of CMP at wk8 by Pb exposure was mediated by increased IRF8 expression. IRF8 is a nuclear factor that is known to impact myelopoiesis in mice. Studies investigating the mechanisms of IRF8 regulation on myelopoiesis have suggested that several different pathways might be involved. Kurotaki et al. reported that IRF8 binds to PU.1 to form a dimer to drive monopoiesis in myeloid progenitors (Kurotaki et al., 2013) , whereas IRF8 conjugates with C/EBPa to form a dimer to inhibit neutrophil generation in mice (Kurotaki et al., 2014) , indicating IRF8 promotes monopoiesis while suppressing granulopoiesis. On the other hand, IRF8 was also reported to reduce the numbers of both monocyte/ macrophage and neutrophil progenitors likely through increased apoptosis and reduced proliferation of the progenitors in vitro (Yanez et al., 2015) . In addition, another study reported that IRF8 deficient mice had increased neutrophils and monocytes in the peripheral blood and BM (Holtschke et al., 1996) . These studies indicate that IRF8 may suppress both monopoiesis and granulopoiesis under certain conditions. Therefore, the influences of IRF8 on myelopoiesis are complex. Of note, mouse models or in vitro systems in the aforementioned studies were all absolutely IRF8 deficient, which differ from our setting in this study, and therefore the mechanisms of IRF8 regulation on myelopoiesis might also be different. In Pb-treated mice, the expression of IRF8 was increased in CMP while it was comparable in GMP in the BM. This might be due to the fact that IRF8 expression in GMP became extremely high even in control mice and thus the Pb effect on upregulation of IRF8 was dispensable. Because no difference of IRF8 expression in GMP was observed by Pb exposure, it is likely that the key role of increased IRF8 by Pb was impeding the differentiation of CMP into GMP, rather than regulating the differentiation of GMP into monocytes and neutrophils, during Pb treatment. This hypothesis is supported by the observation that both monocytes and neutrophils were decreased after Pb treatment for 8 weeks, rather than a bias to Figure 5 . Pb enhanced ROS production and accelerated GMP differentiation at wk1 in mice. B6 mice were treated with or without Pb for 1 or 8 weeks, and ROS production as well as their role in myeloid progenitor differentiation was evaluated. A, ROS expression indicated by DCFH-DA mean fluoresce intensity in BM CMP and GMP at wk1 and wk8 during Pb treatment. B, Schematic of antioxidant NAC treatment and GMP differentiation as for (C). Because GMP from Pb-treated mice had more ROS than those of control mice, a high dose (5 mM) and a low dose (0.5 mM) of NAC were used for Pb group and a low dose of NAC was used for the control. C, Quantification of monocytes (day 4: Pb þ media > control þ media > control þ 0.5 mM NAC ¼ Pb þ 0.5 mM NAC ¼ Pb þ 5 mM NAC) and neutrophils (day 4: 4 and 5 mice were used for the control and Pb group at wk1, respectively; 5 mice were used for each group at wk8. For (C), 8 mice were used for each group. For (D), 9, 7, 6, and 6 mice were used for the control, Pb group, Pb þ vitamin C and Pb þ melatonin, respectively. Asterisk indicates a significant difference relative to the counterpart control or as indicated. n.s. indicates no significant differences.
increased monocyte production. In addition, human subjects with higher blood Pb concentrations also had reduced numbers of GMP and mature myeloid cells, but not those of lymphocytes, in the peripheral bloods, indicating an occupationally relevant level of Pb exposure also preferentially influences myelopoiesis in humans. Moreover, the positive correlation between human blood Pb concentration and IRF8 expression in CMP suggests that Pb might also suppress myelopoiesis via upregulating IRF8 expression in CMP from humans. Since Pb workers had relatively long Pb-exposure period, myelopoiesis regulated by IRF8, rather than ROS, might be more important in humans during Pb exposure. 
in the absence or presence of shRNA specific to IRF8 as shown in (C). Data were from 2 independent experiments. For (B), each dot represents 1 mouse. About 11 mice were used for the control; 10 and 7 mice were used for Pb group at wk1 and wk8, respectively. For (E), 8 mice were used for each group. Asterisk indicates a significant difference relative to the counterpart control, and n.s. indicates no significant differences.
Of note, Pb had significantly different effects on GMP and CMP in mice at wk1 and wk8. In the BM, HSPC are regulated by the microenvironment (eg, niche) comprised of multiple types of cells such as osteoblasts and MSC (Reagan and Rosen, 2016) . In addition to cell types, growth factors and cytokines are also crucial in maintaining HSPC (Mirantes et al., 2014; Rohban et al., 2017) . Because we did not observe a significant histological alteration in bones of mice during the whole Pb-exposure period, the enhanced inflammatory environment in the BM by Pb exposure likely played a pivotal role in Pb influences on myeloid progenitors at wk8. At wk1, ROS was only induced in GMP, but not in CMP. One hypothesis is that Pb might preferentially accumulate in GMP rather than CMP. In future studies, it would be useful to quantify Pb content in myeloid progenitors to test . Pb did not damage the bone structure but induced multiple cytokine expressions in sera and BM homogenates in mice at wk8. B6 mice were treated with or without Pb for 1 or 8 weeks, and bone structure was evaluated via HE staining and various cytokines in sera and BM homogenates were quantified via Luminex or ELISA. A, Representative histological sections of legs after HE staining. B, Various cytokine expressions in sera. C, Various cytokine expressions in BM homogenates. For (A), 4 mice were used for each group. For (B) and (C), each dot represents 1 mouse. For (B), 20, 14, and 7 mice were used in MIG assay for the control, Pb wk1, and Pb wk8, respectively; 8 mice were used in all other cytokine detection for each group. For (C), 13, 7, and 7 mice were used in MIG assay for the control, Pb wk1, and Pb wk8, respectively; 11, 12, and 8 mice were used in all other cytokine detection for the control, Pb wk1, and Pb wk8, respectively. Asterisk indicates a significant difference relative to the counterpart control. increases ROS production in GMP, leading to augmented GMP differentiation and increased numbers of monocytes and neutrophils. In this process, the number of GMP is exhausted due to accelerated GMP differentiation. At late stage, Pb induces an inflammatory environment and suppresses CMP differentiation by upregulating IRF8 expression, resulting in reduced number of GMP and the consequent decreased amount of monocytes and neutrophils.
whether the distinct effects of Pb on GMP and CMP were due to different amount of Pb accumulations in these cells. The ROS induction in GMP by Pb was diminished at wk8, which was possibly due to an alteration of BM microenvironment, in particular, the increased Th2 response or M2 macrophage-related cytokines such as IL-4 and IL-10 (Tang et al., 2017; Vieira-Potter, 2014) . Moreover, because IRF8 expression can be induced by various cytokines such as IFNc (Vila-del Sol et al., 2008) , the enhanced inflammatory environment in the BM in mice at wk8 may contribute to the Pb-upregulated IRF8 expression in CMP.
In conclusion, as summarized in Figure 9 , we report that an occupationally relevant level of Pb exposure selectively affects myelopoiesis at the myeloid progenitor levels, resulting in a transient increase but eventually a decrease of mature myeloid cells.
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